Closed consultation: Canadian Access, Watch, Reserve classification of antimicrobial drugs for human use
Current status: Closed
This consultation ran from April 9, 2026 to June 8, 2026.
Health Canada sought stakeholder feedback on the proposed Canadian Access, Watch, Reserve (CAN-AWaRe) classification of antimicrobial drugs for human use.
We will consider all comments received before finalizing the CAN-AWaRe classification.
Read the notice to learn more about the CAN-AWaRe classification.
Who was the focus of this consultation
We engaged stakeholders who focus on public health and infectious diseases, including:
- nurses
- industry
- academia
- physicians
- pharmacists
- nurse practitioners
- Indigenous partners
- other health care professionals
- public health agencies and departments
Key questions for discussion
We sought feedback on the proposed CAN-AWaRe classification, asking respondents whether they agreed with Health Canada’s classifications or to suggest alternatives with rationale and supporting evidence. The input that was gathered through this process will be used to finalize the classification.
Contact us
Pharmaceutical Drugs Directorate
Health Products and Food Branch
Address Locator: 0202B
Health Canada
Ottawa, ON, K1A 0K9
Email: amr-ram@hc-sc.gc.ca